ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
First Trust Small Cap Value AlphaDEX Fund

First Trust Small Cap Value AlphaDEX Fund (FYT)

55.1834
0.5431
(0.99%)
마감 05 1월 6:00AM
55.21
0.0266
(0.05%)
시간외 거래: 9:59AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
55.1834
매수가
47.58
매도가
63.29
거래량
9,306
54.50 일간 변동폭 55.24
50.09 52주 범위 61.50
market_cap
전일 종가
54.6403
개장가
54.9046
최근 거래 시간
100
@
55.1834
마지막 거래 시간
재정 규모
US$ 511,026
VWAP
54.9136
평균 볼륨(3m)
12,480
발행 주식
3,200,000
배당수익률
-
주가수익률
6.08
주당순이익(EPS)
9.09
매출
4.25M
순이익
29.08M

First Trust Small Cap Value AlphaDEX Fund 정보

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Nasdaq AlphaDEX Small Cap Value Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the co... The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Nasdaq AlphaDEX Small Cap Value Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the index. The index is designed to select value stocks from the NASDAQ US 700 Small Cap Index (the base index) that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX selection methodology. 더 보기

섹터
Mgmt Invt Offices, Open-end
산업
Mgmt Invt Offices, Open-end
본부
Boston, Massachusetts, USA
설립됨
-
First Trust Small Cap Value AlphaDEX Fund is listed in the Mgmt Invt Offices, Open-end sector of the 나스닥 with ticker FYT. The last closing price for First Trust Small Cap Va... was US$54.64. Over the last year, First Trust Small Cap Va... shares have traded in a share price range of US$ 50.09 to US$ 61.50.

First Trust Small Cap Va... currently has 3,200,000 shares in issue. The market capitalisation of First Trust Small Cap Va... is US$174.85 million. First Trust Small Cap Va... has a price to earnings ratio (PE ratio) of 6.08.

FYT 최신 뉴스

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 138 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 129 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 135 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 120 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 133 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 102 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 127 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 124 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.33010.60178694809654.853355.4654.053070454.6704793SP
4-4.1675-7.0217974790659.350960.0954.051276955.84544383SP
121.11342.0591825411554.0761.553.71471248055.96592198SP
263.40346.5728080339951.7861.550.551625955.60157598SP
521.12342.0780614132454.0661.550.091516954.10532559SP
1561.86343.4947486871753.3261.540.432743448.61959277SP
26017.413446.103786073637.7761.518.923137646.57440827SP

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.08M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.62M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
155.16k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
967.95k
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.4M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
330.82M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
222.72M
ElectricMountain53 ElectricMountain53 2 분 전
What Lebby said has got no value anymore. He also said deals were around the corner and many other things that haven´t come to fruition. Now he´s fired.
Let´s just wait what Yves has to say next week!!
You posting so much seems like pumping before the 9th!
Are you afraid of wh
LWLG
igotthemojo igotthemojo 25 분 전
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 28 분 전
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 35 분 전
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 47 분 전
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 49 분 전
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 51 분 전
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 52 분 전
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 52 분 전
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 54 분 전
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 55 분 전
The Russes hit the jackpot?
BDEZ BDEZ 57 분 전
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 57 분 전
Not good, thanks for sharing.
sand sand 1 시간 전
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 1 시간 전
Moving hard soon 
EFSH
mining101 mining101 1 시간 전
Superb
MEGL
benz280c benz280c 1 시간 전
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 1 시간 전
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 1 시간 전
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 1 시간 전
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 1 시간 전
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 1 시간 전
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD